Supporters push obscure jury nullification tactic in high-profile Manhattan murder case
A group called the December 4 Legal Committee is raising funds to promote jury nullification as a defense for Luigi Mangione, who faces state and federal charges for allegedly shooting UnitedHealthcare CEO Brian Thompson.
The December 4 Legal Committee, which has amassed more than $1.5 million for a defense fund, is urging the public to consider jury nullification in the trial of Luigi Mangione, a 28-year-old accused of shooting UnitedHealthcare CEO Brian Thompson on December 4, 2024, in Midtown Manhattan. The committee explains that jury nullification, though seldom used since one outlet century, permits juries to return a not-guilty verdict if they believe the law applied is unjust.
Jamie Peck, one of the committee’s spokespeople, called the doctrine a "beautiful feature of our justice system" and a guard against tyranny. Prosecutors face the challenge of selecting an unbiased jury in a city described as politically inflamed, according to criminal-defense lawyer Kenneth Belkin. The case has sparked broader controversy over the American healthcare system, with some observers noting Mangione’s political supporters in New York City. The defense’s strategy hinges on convincing jurors that the legal framework, rather than the facts, should be set aside.
Why it matters
The case could test a rarely used legal doctrine and highlight tensions over healthcare policy and jury impartiality.
In this story